Sunday, July 15, 2007

 Max

 Max Re slashes hedge fund allocation after $31 mln loss

 News   Feeds  (Related)    Tags  (Related)    Search Shortcuts  (Related)  FeedsFarm.com >  Max Re slashes hedge fund allocation after $31 mln loss
 Max Re slashes hedge fund allocation after $31 mln loss

 14th Nov 2006, 01:05 GMT

 SAN FRANCISCO (MarketWatch) -- Max Re Capital slashed the amount of money it's willing to invest in hedge funds after the Bermuda-based reinsurer's alternative investment portfolio lost $31 million during the third quarter.

Max Re slashes hedge fund allocation after $31 mln loss related news:  (Related)  Max Re slashes hedge fund allocation after $31 mln lossBusiness and philanthropy in a sometimes rocky union  (Related)   — Europe - International Herald Tribune  (Related) Investcorp partners US hedge fund  (Related)   — AME Info News - Finance and Economy  (Related) Large hits at London's hedge fund listing ban  (Related)   — TimesOnline: Business  (Related) Marshall Wace plans £1bn fund  (Related)   — Telegraph Business  (Related) Marshall Wace Plans Hedge-Fund IPO  (Related)   — WSJ.com: What's News Europe  (Related) Fortis Investments acquires majority stake in fund of hedge funds firm  (Related)   — Banking Business Review Latest News  (Related) Marshall Wace aims for €1.5bn listing  (Related)   — FT.com - UK Homepage  (Related) A billion-dollar hedge manager who drives a Honda  (Related)   — Business - International Herald Tribune  (Related) SEC expects to pursue more hedge fund suits  (Related)   — Boston Globe -- Business News  (Related) The Edwards Lifesciences Fund Awards More Than $1 mln in Charitable Grants  (Related)   — Cardiology News from StratCenter.com  (Related)  Latest news from  MarketWatch.com - Top Stories – Sponsored by: CyberTrader :Toyota plans for 15% global market share by 2010  (Related) Tokyo shares lead region lower; Mining shares tumble in Sydney  (Related) Google's builds a premium feature, one page at a time  (Related) The L.A. Times is dying by a thousand cuts  (Related) Dines' day dawning?  (Related) KB Home CEO resigns after backdating probe  (Related) Drug stocks pare gains; Solexa, Isis shares soar  (Related) Solexa's shares soar on $600 million buyout by Illumina  (Related) Isis Pharma's shares soar on cholesterol-drug Phase II data  (Related) D.R. Horton's profit seen lower with key housing data on tap  (Related) 

No comments: